HIGH-YIELD EXPRESSION OF FUNCTIONALLY ACTIVE HUMAN LIVER CYP2D6 IN YEAST-CELLS

Citation
Ey. Krynetski et al., HIGH-YIELD EXPRESSION OF FUNCTIONALLY ACTIVE HUMAN LIVER CYP2D6 IN YEAST-CELLS, Pharmacogenetics, 5(2), 1995, pp. 103-109
Citations number
26
Categorie Soggetti
Pharmacology & Pharmacy","Genetics & Heredity
Journal title
ISSN journal
0960314X
Volume
5
Issue
2
Year of publication
1995
Pages
103 - 109
Database
ISI
SICI code
0960-314X(1995)5:2<103:HEOFAH>2.0.ZU;2-K
Abstract
In order to develop a model system for studying drug metabolism, we co nstructed recombinant yeast strains expressing human liver cytochromes P450. A high yield of cDNA-derived CYP2D6 was obtained, due to optimi zation of the initiation ATG codon context, The PCR-based site-mutagen esis method was used to introduce an AAA sequence immediately before t he initiation codon resulting in increased translation of the GAL10-CY Cl-derived mRNA. The use of a peptidase-deficient yeast strain also he lped to increase the CYP2D6 content, A P450 content of 250 +/- 30 pmol per mg of microsomal protein was achieved, HPLC analysis confirmed th at heterologously expressed CYP2D6 catalysed the oxidation of debrisoq uine and dextromethorphan, two prototype substrates for CYP2D6. The K- m for debrisoquine 4-hydroxylase was found to be 50 mu M and V-max 7.5 pmol mg(-1) min(-1). Dextromethorphan O-demethylase activity in CYP2D 6-containing microsomes was characterized by K-m 8.5 mu M and V-max 70 0 pmol mg(-1) min(-1). Biotransformation of debrisoquine and dextromet horphan was not detected in control microsomes. Yeast synthesizing CPP 2D6 represents a useful in vitro system for studying xenobiotic metabo lism.